CAR T-cell therapy in the United Kingdom typically costs from $350,000 to $500,000. Prices depend on the specific drug used, clinical monitoring requirements, and the hospital stay duration. In the US, similar procedures cost around $525,000 on average. Patients save around 33% compared to US rates. Total costs usually cover cell collection, genetic engineering, and chemotherapy.
- Hospitalization and monitoring: Covers the essential 28-day stay for cytokine release syndrome observation.
- London premium: Specialized clinics in London typically cost 20% more than regional centers.
- Cell processing: Includes apheresis and laboratory modification of T-cells for targeted cancer therapy.
- Pre-treatment chemotherapy: Covers lymphodepletion protocols required before the engineered cells are reinfused.
Bookimed Expert Insight: Choosing the largest private clinics provides access to top-tier safety infrastructure. Wellington Hospital in London serves as a primary hub within the HCA Healthcare UK network. This provides patients with integrated urgent care support during the intensive monitoring phase. High-volume centers often offer better value by bundling complex ICU monitoring into the total price. This ensures no unexpected costs arise during the recovery period.